The invention relates to a newly identified tumor suppressor gene,
designated DOS (for Deleted in Osteosarcoma and alternatively referred to
herein as DOCK 3) which has been cloned from human and mouse cells. The
DOS nucleic acid and protein molecules and their use in the diagnosing
and treating disorders characterized by aberrant DOS molecule expression
are described.